Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Discover which cards provide rewards without annual fees. Enjoy benefits while keeping your expenses low.
26,068 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
February can be a pivotal month for tech investing. This guide reveals three top tech stocks february to consider, pl...
Investors are scanning for AI leaders beyond the obvious names. This article builds a case for why Broadcom could be ...
Insider buying can reveal confidence that outsiders may miss. This guide breaks down how to read the signals, separat...
Midday trading shows inflation fears and global tensions pressing equities. This update breaks down what’s moving the...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...
IBM argues that data gravity keeps information in place. This investing piece explains why that matters, how AI reinf...
Leveraged ETFs promise outsized gains, but they are built for daily moves, not long-term investing. This guide breaks...
Think AI stocks can’t deliver both growth and income? This piece reveals two surprising dividend plays that tap AI tr...
Coeur stock dropped again as inflation signals and gold prices shifted. This article breaks down what happened, what ...
Retirees who claimed social security here’s at 62 may still see bigger monthly checks later, thanks to a do-over rule...
JetBlue Airways sparked a rally as reports surfaced about a strategic review, including a possible sale. Here’s what ...